201
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Does saffron supplementation have favorable effects on liver function indicators? A systematic review and meta-analysis of randomized controlled trials

, , , , , ORCID Icon, , & show all

References

  • Abdullaev, F. I. 2002. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Experimental Biology and Medicine (Maywood, N.J.) 227 (1):20–5. doi: 10.1177/153537020222700104.
  • Abedimanesh, N.,. S. Z. Bathaie, S. Abedimanesh, B. Motlagh, A. Separham, and A. Ostadrahimi. 2017. Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease. Journal of Cardiovascular and Thoracic Research 9 (4):200–8. doi: 10.15171/jcvtr.2017.35.
  • ALMODóVAR, P., D. Briskey, A. Rao, M. Prodanov, and A. M. Inarejos-GARCíA. 2020. 2020. Bioaccessibility and pharmacokinetics of a commercial saffron (Crocus sativus L.) extract. Evidence-Based Complementary and Alternative Medicine 2020:1–8. doi: 10.1155/2020/1575730.
  • Amin, A., A. A. Hamza, K. Bajbouj, S. S. Ashraf, and S. Daoud. 2011. Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology (Baltimore, Md.) 54 (3):857–67. doi: 10.1002/hep.24433.
  • Asbaghi, O., M. Sadeghian, O. Sadeghi, S. Rigi, S. C. Tan, A. Shokri, and S. M. Mousavi. 2021. Effects of saffron (Crocus sativus L.) supplementation on inflammatory biomarkers: A systematic review and meta-analysis. Phytotherapy Research. 35 (1):20–32. doi: 10.1002/ptr.6748.
  • Ashktorab, H., A. Soleimani, G. Singh, A. Amr, S. Tabtabaei, G. Latella, U. Stein, S. Akhondzadeh, N. Solanki, M. C. Gondré-Lewis, et al. 2019. Saffron: The golden spice with therapeutic properties on digestive diseases. Nutrients 11 (5):943., doi: 10.3390/nu11050943.
  • Asrani, S. K., H. Devarbhavi, J. Eaton, and P. S. Kamath. 2019. Burden of liver diseases in the world. Journal of Hepatology 70 (1):151–71. doi: 10.1016/j.jhep.2018.09.014.
  • Bandegi, A. R., A. Rashidy-Pour, A. A. Vafaei, and B. Ghadrdoost. 2014. Protective effects of Crocus sativus L. extract and crocin against chronic-stress induced oxidative damage of brain, liver and kidneys in rats. Advanced Pharmaceutical Bulletin 4:493.
  • Bhattacharjee, B.,. S. Vijayasarathy, P. Karunakar, and J. Chatterjee. 2012. Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pacific Journal of Cancer Prevention : APJCP 13 (11):5605–11. doi: 10.7314/apjcp.2012.13.11.5605.
  • Bhatti, I. U., F. U. Rehman, M. A. Khan, and S. K. Marwat. 2009. Effect of prophetic medicine Kalonji (Nigella sativa L.) on lipid profile of human beings: An in vivo approach. World Applied Sciences Journal 6:1053–7.
  • Borenstein, M., L. Hedges, J. Higgins, and H. Rothstein. 2009. References. Wiley online library.
  • Borenstein, M., L. V. Hedges, J. P. Higgins, and H. R. Rothstein. 2011. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons.
  • Chen, Y., T. Yang, J. Huang, X. Tian, C. Zhao, L. Cai, L. Feng, and H. Zhang. 2010. Comparative evaluation of the antioxidant capacity of crocetin and crocin in vivo. Chinese Pharmacological Bulletin 26:248–51.
  • Dehghan, F., F. Hajiaghaalipour, A. Yusof, S. Muniandy, S. A. Hosseini, S. Heydari, L. Z. A. Salim, and M. A. Azarbayjani. 2016. Saffron with resistance exercise improves diabetic parameters through the GLUT4/AMPK pathway in-vitro and in-vivo. Scientific Reports 6 (1):25139. doi: 10.1038/srep25139.
  • Dersimonian, R., and R. Kacker. 2007. Random-effects model for meta-analysis of clinical trials: An update. Contemporary Clinical Trials 28 (2):105–14. doi: 10.1016/j.cct.2006.04.004.
  • Dufour, D. R., J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff. 2000. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Laboratory Guidelines for Screening, Diagnosis and Monitoring of Hepatic Injury. Retrieved August, 30, 2003.
  • Ebrahimi, F., N. Aryaeian, N. Pahlavani, D. Abbasi, A. F. Hosseini, S. Fallah, N. Moradi, and I. Heydari. 2019. The effect of saffron (Crocus sativus L.) supplementation on blood pressure, and renal and liver function in patients with type 2 diabetes mellitus: A double-blinded, randomized clinical trial. Avicenna Journal of Phytomedicine 9:322.
  • Fan, J., and I. Gijbels. 1996. Local polynomial modelling and its applications: monographs on statistics and applied probability. Vol. 66. USA: CRC Press.
  • Farahmand, S. K., F. Samini, M. Samini, and S. Samarghandian. 2013. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver. Biogerontology 14 (1):63–71. doi: 10.1007/s10522-012-9409-0.
  • Feher, J., and G. Lengyel. 2012. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology 13 (1):210–7. doi: 10.2174/138920112798868818.
  • Fitzmaurice, C., D. Dicker, A. Pain, H. Hamavid, M. Moradi-Lakeh, M. F. MacIntyre, C. Allen, G. Hansen, R. Woodbrook, C. Wolfe, et al. 2015. The Global Burden of Cancer 2013. JAMA Oncology 1 (4):505–27., doi: 10.1001/jamaoncol.2015.0735.
  • Hemmati, M.,. S. Asghari, E. Zohoori, and M. Karamian. 2015. Hypoglycemic effects of three Iranian edible plants; jujube, barberry and saffron: Correlation with serum adiponectin level. Pakistan Journal of Pharmaceutical Sciences 28 (6):2095–9.
  • Higgins, J. P., D. G. Altman, P. C. GøTZSCHE, P. Juni, D. Moher, A. D. Oxman, J. Savović, K. F. Schulz, L. Weeks, and J. A. Sterne. 2011. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343 (oct18 2):d5928–d5928. doi: 10.1136/bmj.d5928.
  • Hosseinzadeh, H., and H. Sadeghnia. 2007. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: Involvement of GABAergic and opioids systems. Phytomedicine 14 (4):256–62. doi: 10.1016/j.phymed.2006.03.007.
  • Hosseinzadeh, H.,. F. Shamsaie, and S. Mehri. 2009. Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacognosy Magazine 5:419.
  • Hozo, S. P., B. Djulbegovic, and I. Hozo. 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 5 (1):13. doi: 10.1186/1471-2288-5-13.
  • Imenshahidi, M.,. H. Hosseinzadeh, and Y. Javadpour. 2010. Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytotherapy Research : PTR 24 (7):990–4. doi: 10.1002/ptr.3044.
  • Jiang, X., A. Awati, A. Agazzi, F. Vitari, A. Ferrari, H. Bento, M. Crestani, C. Domeneghini, and V. Bontempo. 2015. Effects of a blend of essential oils and an enzyme combination on nutrient digestibility, ileum histology and expression of inflammatory mediators in weaned piglets. Animal 9 (3):417–26. doi: 10.1017/S1751731114002444.
  • Jose Bagur, M., G. L. Alonso Salinas, A. M. Jimenez-Monreal, S. Chaouqi, S. Llorens, M. MARTíNEZ-Tome, and G. L. Alonso. 2017. Saffron: An old medicinal plant and a potential novel functional food. Molecules 23 (1):30. doi: 10.3390/molecules23010030.
  • Karimi, E., E. Oskoueian, R. Hendra, and H. Z. Jaafar. 2010. Evaluation of Crocus sativus L. stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules (Basel, Switzerland) 15 (9):6244–56. doi: 10.3390/molecules15096244.
  • Khorasany, A. R., and H. Hosseinzadeh. 2016. Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: A review. Iranian Journal of Basic Medical Sciences 19:455.
  • Konstantopoulos, P.,. I. P. Doulamis, A. Tzani, M. L. Korou, E. Agapitos, I. S. Vlachos, V. Pergialiotis, C. Verikokos, G. Mastorakos, and N. L. Katsilambros. 2017. Metabolic effects of Crocus sativus and protective action against non-alcoholic fatty liver disease in diabetic rats. Biomedical Reports 6:513–8.
  • Kunutsor, S. K., T. A. Apekey, and J. Walley. 2013. Liver aminotransferases and risk of incident type 2 diabetes: A systematic review and meta-analysis. American Journal of Epidemiology 178 (2):159–71. doi: 10.1093/aje/kws469.
  • Liu, Z. L., L. Z. Xie, J. Zhu, G. Q. Li, S. J. Grant, and J. P. Liu. 2013. Herbal medicines for fatty liver diseases. Cochrane Database of Systematic Reviews 24 (8):CD009059.
  • Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380 (9859):2095–128., doi: 10.1016/S0140-6736(12)61728-0.
  • Mansoori, P., S. Akhondzadeh, F. Raisi, P. Ghaeli, A. Jamshidi, A. Nasehi, H. Sohrabi, and S. Saroukhani. 2011. A randomized, double-blind, placebo-controlled study of safety of the adjunctive saffron on sexual dysfunction induced by a selective serotonin reuptake inhibitor. Journal of Medicinal Plants 10:121–30.
  • Mashmoul, M.,. A. Azlan, B. N. M. Yusof, H. Khaza'Ai, N. Mohtarrudin, and M. T. Boroushaki. 2014. Effects of saffron extract and crocin on anthropometrical, nutritional and lipid profile parameters of rats fed a high fat diet. Journal of Functional Foods 8:180–7. doi: 10.1016/j.jff.2014.03.017.
  • Mashmoul, M.,. A. Azlan, N. Mohtarrudin, B. N. Mohd Yusof, H. Khaza'ai, H. E. Khoo, M. Farzadnia, and M. T. Boroushaki. 2016. Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats. BMC Complementary and Alternative Medicine 16 (1):401 doi: 10.1186/s12906-016-1381-9.
  • Milajerdi, A., S. Jazayeri, V. Bitarafan, N. Hashemzadeh, E. Shirzadi, Z. Derakhshan, M. Mahmoodi, A. Rayati, A. Djazayeri, and S. Akhondzadeh. 2017. The effect of saffron (Crocus sativus L.) hydro-alcoholic extract on liver and renal functions in type 2 diabetic patients: A double-blinded randomized and placebo control trial. Journal of Nutrition & Intermediary Metabolism 9:6–11. doi: 10.1016/j.jnim.2017.07.002.
  • Mohamadpour, A. H., Z. Ayati, M. R. Parizadeh, O. Rajbai, and H. Hosseinzadeh. 2013. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iranian Journal of Basic Medical Sciences 16 (1):39–46.
  • Moher, D., L. Shamseer, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, and L. A. Stewart. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 4:1 doi: 10.1186/2046-4053-4-1.
  • Moravej Aleali, A., R. Amani, H. Shahbazian, F. Namjooyan, S. M. Latifi, and B. Cheraghian. 2019. The effect of hydroalcoholic Saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: A randomized double‐blind clinical trial. Phytotherapy Research 33 (6):1648–57. doi: 10.1002/ptr.6351.
  • Mousavi, B., S. Z. Bathaie, F. Fadai, Z. Ashtari, N. Ali Beigi, S. Farhang, S. Hashempour, N. Shahhamzei, and H. Heidarzadeh. 2015. Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia. Avicenna Journal of Phytomedicine 5 (5):413–9.
  • Mousavi, S. M., E. Karimi, M. Hajishafiee, A. Milajerdi, M. R. Amini, and A. Esmaillzadeh. 2020. Anti-hypertensive effects of cinnamon supplementation in adults: A systematic review and dose-response Meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 60 (18):3144–54.
  • Mousavi, S. M., K. Djafarian, A. Mojtahed, H. K. Varkaneh, and S. Shab-Bidar. 2018. The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. European Journal of Pharmacology 834:10–6. doi: 10.1016/j.ejphar.2018.07.019.
  • Mousavi, S. M., S. Shab-Bidar, H. Kord-Varkaneh, M. Khorshidi, and K. Djafarian. 2019b. Effect of alpha-lipoic acid supplementation on lipid profile: A systematic review and meta-analysis of controlled clinical trials. Nutrition (Burbank, Los Angeles County, Calif.) 59:121–30. doi: 10.1016/j.nut.2018.08.004.
  • Mousavi, S.,. A. Milajerdi, A. Sheikhi, H. Kord‐Varkaneh, C. Feinle‐Bisset, B. Larijani, and A. Esmaillzadeh. 2019a. Resveratrol supplementation significantly influences obesity measures: A systematic review and dose–response meta‐analysis of randomized controlled trials. Obesity Reviews 20 (3):487–98. doi: 10.1111/obr.12775.
  • Muniraman, H., D. Gardner, J. Skinner, A. Paweletz, A. Vayalakkad, Y. H. Chee, C. Clifford, S. Sanka, V. Venkatesh, A. Curley, et al. 2017. Biomarkers of hepatic injury and function in neonatal hypoxic ischemic encephalopathy and with therapeutic hypothermia. European Journal of Pediatrics 176 (10):1295–303., doi: 10.1007/s00431-017-2956-2.
  • Papandreou, M. A., C. D. Kanakis, M. G. Polissiou, S. Efthimiopoulos, P. Cordopatis, M. Margarity, and F. N. Lamari. 2006. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents . J Agric Food Chem 54 (23):8762–8. doi: 10.1021/jf061932a.
  • Parsi, A., M. Torkashvand, E. Hajiani, M. Rahimlou, and N. Sadeghi. 2020. The effects of crocus sativus extract on serum lipid profile and liver enzymes in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled study. Obesity Medicine 17:100165. doi: 10.1016/j.obmed.2019.100165.
  • Pour, F. K., N. Aryaeian, M. Mokhtare, R. S. Mirnasrollahi Parsa, L. Jannani, S. Agah, S. Fallah, and N. Moradi. 2020. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial . Phytotherapy Research : PTR 34 (12):3367–78. doi: 10.1002/ptr.6791.
  • Promrat, K., D. E. Kleiner, H. M. Niemeier, E. Jackvony, M. Kearns, J. R. Wands, J. L. Fava, and R. R. Wing. 2010. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51 (1):121–9. doi: 10.1002/hep.23276.
  • Rahmani, J., A. Miri, I. Namjoo, N. Zamaninour, M. B. Maljaei, K. Zhou, R. Cerneviciute, S. M. Mousavi, H. K. Varkaneh, A. Salehisahlabadi, et al. 2019. Elevated liver enzymes and cardiovascular mortality: A systematic review and dose-response meta-analysis of more than one million participants . European Journal of Gastroenterology & Hepatology 31 (5):555–62., doi: 10.1097/MEG.0000000000001353.
  • Ramli, F. N., A. Abu Bakar Sajak, F. Abas, Z. A. Mat Daud, and A. Azlan. 2020. Effect of Saffron Extract and Crocin in Serum Metabolites of Induced Obesity Rats. BioMed Research International 2020:1–15. doi: 10.1155/2020/1247946.
  • Ruhl, C. E., and J. E. Everhart. 2009. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population . Gastroenterology 136 (2):477–85. doi: 10.1053/j.gastro.2008.10.052.
  • Schmidt, M.,. G. Betti, and A. Hensel. 2007. Saffron in phytotherapy: Pharmacology and clinical uses. Wiener Medizinische Wochenschrift (1946) 157 (13-14):315–9. doi: 10.1007/s10354-007-0428-4.
  • Sepahi, S.,. S. A. Mohajeri, S. M. Hosseini, E. Khodaverdi, N. Shoeibi, M. Namdari, and S. A. S. Tabassi. 2018. Effects of Crocin on diabetic maculopathy: A placebo-controlled randomized clinical trial. American Journal of Ophthalmology 190:89–98. doi: 10.1016/j.ajo.2018.03.007.
  • Serrano-DíAZ, J., A. M. SáNCHEZ, M. MARTíNEZ-Tome, P. Winterhalter, and G. L. Alonso. 2013. A contribution to nutritional studies on Crocus sativus flowers and their value as food. Journal of Food Composition and Analysis 31 (1):101–8. doi: 10.1016/j.jfca.2013.03.009.
  • Shamsi-Baghbanan, H., A. Sharifiyan, S. Esmaeili, and B. Minaei. 2014. Hepatoprotective herbs, avicenna viewpoint. Iranian Red Crescent Medical Journal 16 (1):e12313. doi: 10.5812/ircmj.12313.
  • Tung, N. H., and Y. Shoyama. 2013. New minor glycoside components from saffron. Journal of Natural Medicines 67 (3):672–6. doi: 10.1007/s11418-012-0721-4.
  • Xia, J., I. V. Sinelnikov, B. Han, and D. S. Wishart. 2015. MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Research 43 (W1):W251–257. doi: 10.1093/nar/gkv380.
  • Xiong, F., and Y.-S. Guan. 2017. Cautiously using natural medicine to treat liver problems. World Journal of Gastroenterology 23 (19):3388–95. doi: 10.3748/wjg.v23.i19.3388.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.